All AbMole products are for research use only, cannot be used for human consumption.

MHY1485 induced mTOR activation and correspondingly showed a higher docking score than PP242, a well-known ATP-competitive mTOR inhibitor, in docking simulation. In conclusion, MHY1485 has an inhibitory effect on the autophagic process by inhibition of fusion between autophagosomes and lysosomes leading to the accumulation of LC3II protein and enlarged autophagosomes. MHY1485 also induces mTOR activity, providing a possibility for another regulatory mechanism of autophagy by the MHY compound. MHY1485 treatment increases ribosomal protein S6 kinase (S6K) and eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) phosphorylation, which are downstream targets of mTOR complex 1 (mTORC1), but decreases phosphorylation of Akt on mTOR complex 2 (mTORC2) target site serine 473.
Int Immunopharmacol. 2024 Sep 21;142(Pt B):113196.
Salidroside treatment decreases the susceptibility of atrial fibrillation in diabetic mice by reducing mTOR-STAT3-MCP-1 signaling and atrial inflammation
MHY1485 purchased from AbMole
Front Pharmacol. 2024 Jul 26;15:1434568.
Huanshaodan regulates microglial glucose metabolism reprogramming to alleviate neuroinflammation in AD mice through mTOR/HIF-1a signaling pathway
MHY1485 purchased from AbMole
Chemical Engineering Journal. 2024 Apr 09.
Novel nano-platinum induces autophagy through dual pathways in the treatment of osteosarcoma in cell lines with different P53 expression patterns
MHY1485 purchased from AbMole
Heliyon. 2023 Jul;9(7):e17551.
Itaconate attenuates autoimmune hepatitis via PI3K/AKT/mTOR pathway-mediated inhibition of dendritic cell maturation and autophagy
MHY1485 purchased from AbMole
Heliyon. 2023 Jun 22;9(7):e17551.
Itaconate attenuates autoimmune hepatitis via PI3K/AKT/mTOR pathway-mediated inhibition of dendritic cell maturation and autophagy
MHY1485 purchased from AbMole
Int J Neurosci. 2022 Jul 18;1-9.
Sinomenine exerts a neuroprotective effect on PD mouse model through inhibiting PI3K/AKT/mTOR pathway to enhance autophagy
MHY1485 purchased from AbMole
Fish Shellfish Immunol. 2020 Jul;102:480-488.
Target of rapamycin signaling inhibits autophagy in sea cucumber Apostichopus japonicus
MHY1485 purchased from AbMole
Life Sci. 2020 Jun 15;251:117595.
The in vitro effects of phospholipase D1-mTOR axis in liver fibrogenesis
MHY1485 purchased from AbMole
| Cell Experiment | |
|---|---|
| Cell lines | CT26 and LLC cells |
| Preparation method | The number of cells was counted with a Countess II FL. According to a previous report, the cells were plated in culture flasks or dishes at Day 0; 10 μM of MHY1485 or vehicle control (DMSO) were added on Day 1 (24 h after cell plating); 6 Gy X-ray irradiation was delivered on Day 2 (24 h after drug treatment) and the culture medium and cells were collected for experiments on Day 3 (24 h after irradiation). |
| Concentrations | 10 μM |
| Incubation time | 24 h |
| Animal Experiment | |
|---|---|
| Animal models | C57BL/6J mice |
| Formulation | DMSO and Saline |
| Dosages | 2 mg/kg |
| Administration | Intraperitoneally injected |
| Molecular Weight | 387.39 |
| Formula | C17H21N7O4 |
| CAS Number | 326914-06-1 |
| Solubility (25°C) | DMSO 7 mg/mL (Need ultrasonic and warming) |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related mTOR Products |
|---|
| AZD8055
AZD8055 is a novel ATP-competitive inhibitor of mTOR kinase (both complexes mTORC1 and mTORC2) with an IC50 of 0.8 nM. |
| Deforolimus
Deforolimus (also known as AP23573 and MK-8669) is an investigational targeted and small-molecule mTOR inhibitor. *The compound is unstable in solutions, freshly prepared is recommended |
| Everolimus
Everolimus (RAD001) also known as SDZ-RAD and Certican is an mTOR inhibitor with IC50 of 0.63 nM. |
| KU-0063794
KU-0063794 is a potent and selective mTOR inhibitor with IC50 values of approximately 10 nM for mTORC1 and mTORC2. |
| WYE-354
WYE-354 is a cell-permeable pyrazolopyrimidine compound that acts as a potent and ATP-competitive mTOR inhibitor (IC50 = 5 nM with S6K as the substrate and 100 µM ATP). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
